JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263367

Human SSNA1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SSNA1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1.

View Alternative Names

N14, NA 14, Nuclear autoantigen of 14 kDa, Sjoegren syndrome nuclear autoantigen 1, Sjogren syndrome nuclear autoantigen 1, Sjogren's syndrome nuclear autoantigen 1

1 Images
Sanger Sequencing - Human SSNA1 knockout HEK-293T cell lysate (AB263367)
  • Sanger seq

Unknown

Sanger Sequencing - Human SSNA1 knockout HEK-293T cell lysate (AB263367)

Homozygous : 1 bp insertion in exon1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263367-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SSNA1 knockout HEK293T cell lysate", "number":"AB263367-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263367-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SSNA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SSNA1 also known as sperm-specific antigen 1 is a protein that plays a mechanical role in cellular functions. It weighs approximately 16 kDa and is expressed predominantly in testicular tissue but can also find expression in other tissues like the brain. SSNA1 operates by facilitating the polymerization of microtubules which are structures critical for maintaining cell shape and enabling cell division. This protein associates with microtubules within cells suggesting a role in the regulation of cytoskeleton dynamics.
Biological function summary

SSNA1 serves functions beyond those of structural support and microtubule association. It acts as a part of the microtubule-associated complex which is integral in cellular transport and mitosis processes. SSNA1 contributes to intracellular cargo transport by supporting the movement of cargo along the microtubule network. Its association in the microtubule complex emphasizes its significance in maintaining a balance of assembly and disassembly of cellular structures for regular cell functioning and division.

Pathways

SSNA1 plays a role in the cytoskeleton signaling pathway notably by interacting with key regulators such as tubulin and microtubule-associated proteins. It's involved in processes such as cell cycle regulation particularly during mitosis. SSNA1's interaction with these proteins implies a contributory role in checkpoint controls that ensure correct cell division. Additionally SSNA1 has an influence on signal transduction pathways that govern cell shape and motility. It works in conjunction with pathways like the MAPK signaling pathway which is central to cellular responses to stress and proliferative signals.

Alterations in SSNA1 expression or function have links to certain neurological conditions. SSNA1 has an association with neurodegenerative diseases where its interaction with proteins such as tau can influence tauopathy conditions possibly due to its involvement in microtubule stability. Another condition linked to SSNA1 is Klinefelter syndrome where its overexpression or irregular activity can lead to symptoms associated with testicular abnormalities. Further studies can aid in understanding how SSNA1 impacts the pathogenesis of these disorders and might provide insights into potential therapeutic targets.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com